Table 1. Characteristics of 908 Patients... | American Society of Hematology

Table 1.

Characteristics of 908 Patients From Studies AIEOP 88 and 91 and Coexpression of MyAg

Patient Characteristics	All Cases		MyAg⁺ALL		MyAg⁻ALL
Patient Characteristics	No.	%	No.	%	No.	%
Total	908	100	291	32	617	68
Sex
Males	517	57	174	60	343	56
Females	391	43	117	40	274	44
Age
<1 yr	23	3	7	2	16	2
1-9 yrs	726	80	238	82	488	79
>10 yrs	159	17	46	16	113	18
Hepatomegaly^-152	216	24	86	30	130	21
Splenomegaly^-152	253	28	81	28	172	28
CNS disease	35	4	6	2	29	5
Hemoglobin >8 g/dL	464	51	152	52	312	51
WBC >50,000/μL	203	22	60	21	143	23
Platelets <50,000/μL	403	44	123	42	280	45
FAB L2	201	22	69	24	132	22
Risk groups
Standard or intermediate	630	69	227	78^*	403	65^*
High	278	31	64	22	214	35
Prednisone good response	732/816	90	242/260	93^-151	490/556	88^-151
CR after induction therapy	864	95	279	96	585	95

Patient Characteristics	All Cases		MyAg⁺ALL		MyAg⁻ALL
Patient Characteristics	No.	%	No.	%	No.	%
Total	908	100	291	32	617	68
Sex
Males	517	57	174	60	343	56
Females	391	43	117	40	274	44
Age
<1 yr	23	3	7	2	16	2
1-9 yrs	726	80	238	82	488	79
>10 yrs	159	17	46	16	113	18
Hepatomegaly^-152	216	24	86	30	130	21
Splenomegaly^-152	253	28	81	28	172	28
CNS disease	35	4	6	2	29	5
Hemoglobin >8 g/dL	464	51	152	52	312	51
WBC >50,000/μL	203	22	60	21	143	23
Platelets <50,000/μL	403	44	123	42	280	45
FAB L2	201	22	69	24	132	22
Risk groups
Standard or intermediate	630	69	227	78^*	403	65^*
High	278	31	64	22	214	35
Prednisone good response	732/816	90	242/260	93^-151	490/556	88^-151
CR after induction therapy	864	95	279	96	585	95

*P = .001.

P = .03.

Below umbilical line.